期刊文献+

左氧氟沙星替代标准三联中的克拉霉素治疗幽门螺杆菌感染93例 被引量:5

Levofloxacin in place of clarithromycin in standard triple therapy for the treatment of Hp:A study of 93 cases
暂未订购
导出
摘要 目的探讨左氧氟沙星替代标准三联中的克拉霉素治疗幽门螺杆菌感染的疗效。方法选取2008年3月~2011年4月在我院就诊经胃镜检查并经尿素酶法测出Hp阳性患者182例,随机分为两组,治疗组93例,对照组89例,治疗组用奥美拉唑、阿莫西林、左氧氟沙星,对照组用奥美拉唑、阿莫西林、克拉霉素,观察两组治疗效果及不良反应。结果治疗组93例有84例幽门螺杆菌转阴,根除率90.3%,对照组89例有66例幽门螺杆菌转阴,根除率74.2%,差异有统计学意义(P<0.05)。结论应用左氧氟沙星替代目前国内推荐的标准三联中的克拉霉素治疗幽门螺杆菌感染根除率较高,值得临床推广应用。 Objective To investigate the effect of levofloxacin in place of clarithromycin in standard triple therapy (omeprazole, amoxicillin and clarithromycin) for the treatment of Helicobacter pylori (Hp). Methods All of 182 patients were sampled from Hospital, whose Hp registered positive after gastroscopy and urease test. They were randomly divided into two groups: treatment group with 93 patients and the control group with 89 cases. Omeprazoie, amoxicillin and lev- ofloxacin were combined in treatment group, whereas omeprazole, amoxicillin and clarithromycin were used in control group. Results The eradication rates of Hp in the treatment group and control group were respectively 90.3% and 74.2%, there were statistically significant differences (P 〈 0.05). Conclusion The application of levofloxacin in place of clarithromycin in standard triple therapy (omeprazole, amoxicillin and clarithromycin) for the treatment of Hp demonstrated better eradica- tion rate, and therefore it was favorably advisable in clinical practice.
出处 《中国现代医生》 2012年第26期151-152,共2页 China Modern Doctor
关键词 左氧氟沙星 幽门螺杆菌 克拉霉素 Levofloxacin Helicobacter pylori Clarithrornycin
  • 相关文献

参考文献6

二级参考文献30

  • 1丁永年,惠明,吴江.泮托拉唑联合克拉霉素、阿莫西林治疗消化性溃疡伴Hp感染80例疗效观察[J].中国现代应用药学,2008,25(z2):743-745. 被引量:10
  • 2李国庆,夏华向.幽门螺杆菌根除治疗、治疗失败的原因及其对策[J].胃肠病学,2005,10(1):37-43. 被引量:40
  • 3黄跃,许鲁宁.环丙沙星一周疗法根除幽门螺杆菌[J].中国新药杂志,1994,3(2):34-36. 被引量:10
  • 4杜光红,陈霞,王忠琼,邓明明,李昌平.三联疗法根除幽门螺杆菌临床观察[J].实用诊断与治疗杂志,2006,20(11):806-808. 被引量:5
  • 5Van der Hulst RWM, Keller JJ, Rauws EAJ, et al. Theatment of Helicobacter pylori infection: a review of the world literature. Helicobacter, 1996,1:6-19.
  • 6Georgopoulos SD, Ladas SD, Karatapanis S, et al. Factors that may affect treatment outcome of triple Helicobacter pylori eradication therapy with omeprazole, amoxicillin, and clarithromycin. Dig Dis Sci,2000 ,45:63-67.
  • 7Piccolomini R, Bonaventura G, Catamo G, et al. Comparative evaluation of the E test, agar dilution, and broth microdilution for testing susceptibilities of Helicobacter pylori strains to 20 antimicrobial agents. J Clin Microbiol,1997,35:1842-1844.
  • 8Pfaller MA, Barry AL, Fuchs PC, et al. Levofloxacin disk potency and tentative interpretive criteria for susceptibility tests. J Clin Microbiol,1993, 31:1924-1926.
  • 9Sharma VK, Vasudeva R, Howden CW. A national survey of gastroenterologists' current opinions and practices related to Hp. Am J Gastroenterol,1998,93:1647-1657.
  • 10Franzin L, Pennazio M, Cabodi D, et al. Clarithromycin and amoxicillin susceptibility of Helicobacter pylori strains isolated from adult patients with gastric or duodenal ulcer in Italy. Curr Microbiol, 2000,40:96-100.

共引文献122

同被引文献40

引证文献5

二级引证文献163

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部